文献速递皮肤肿瘤

85岁以上接受莫氏手术患者的非黑色素瘤皮肤癌:一项前瞻性多中心队列研究

Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery: A Prospective, Multicenter Cohort Study.
PubMed 文献 · JAMA Dermatol · 2022-01-01

这项多中心前瞻性队列研究纳入22个中心的1181例85岁以上转诊莫氏手术的非黑色素瘤皮肤癌患者,其中1078例(91.3%)接受莫氏手术,103例(8.7%)接受替代治疗。接受莫氏手术者面部肿瘤比例更高(68.5% vs 25.2%,P<.001),功能状态高者比例近4倍(57.0% vs 15.5%,P<.001)。作者认为,鉴于肿瘤可能具有侵袭性、疼痛、毁容和引发焦虑,及时手术治疗对高龄患者可能合适。

要点

  • 85岁以上转诊莫氏手术者中91.3%最终接受莫氏手术,8.7%接受替代治疗。
  • 接受莫氏手术者面部肿瘤比例更高(68.5% vs 25.2%,P<.001)。
  • 接受莫氏手术者功能状态高者比例近4倍(57.0% vs 15.5%,P<.001)。

核心结论

  • 研究发现接受莫氏手术的高龄患者常具有高功能状态、高风险肿瘤和面部肿瘤。
  • 作者认为,鉴于肿瘤可能具有侵袭性、疼痛、毁容和引发焦虑,及时手术治疗对高龄患者可能合适。

研究设计与样本

  • 多中心前瞻性队列研究,使用美国私人执业和学术中心的数据。
  • 纳入85岁以上就诊皮肤癌手术并转诊莫氏手术的患者,参照组为85岁以下接受莫氏手术者和85岁以上未接受莫氏手术者。
  • 数据分析时间为2018年11月至2019年1月。

主要发现

  • 1181例85岁以上转诊莫氏手术患者中,1078例(91.3%)接受莫氏手术,103例(8.7%)接受替代治疗。
  • 接受莫氏手术者面部肿瘤比例更高(738例[68.5%] vs 26例[25.2%],P<.001)。
  • 接受莫氏手术者功能状态高者比例近4倍(614例[57.0%] vs 16例[15.5%],P<.001)。
  • 外科医生选择莫氏手术的15种原因中最常见为患者希望高治愈率治疗(712例[66.0%])、患者功能状态好或极好(614例[57.0%])、基于组织学的高风险肿瘤(433例[40.2%])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: It has been suggested that Mohs surgery for skin cancer among individuals with limited life expectancy may be associated with needless risk and discomfort, along with increased health care costs. OBJECTIVE: To investigate patient- and tumor-specific indications considered by clinicians for treatment of nonmelanoma skin cancer in older individuals. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, prospective cohort study was conducted using data from US private practice and academic centers. Included patients were those older than age 85 years presenting for skin cancer surgery and referred for Mohs surgery, with reference groups of those younger than age 85 years receiving Mohs surgery and those older than age 85 years not receiving Mohs surgery. Data were analyzed from November 2018 through January 2019. EXPOSURES: Mohs surgery for nonmelanoma skin cancer. MAIN OUTCOMES AND MEASURES: Reason for treatment selection. RESULTS: Among 1181 patients older than age 85 years referred for Mohs surgery (724 [61.9%] men among 1169 patients with sex data; 681 individuals aged >85 to 88 years [57.9%] among 1176 patients with age data) treated at 22 sites, 1078 patients (91.3%) were treated by Mohs surgery, and 103 patients (8.7%) received alternate treatment. Patients receiving Mohs surgery were more likely to have tumors on the face (738 patients [68.5%] vs 26 patients [25.2%]; P < .001) and nearly 4-fold more likely to have high functional status (614 patients [57.0%] vs 16 patients [15.5%]; P < .001). Of 15 distinct reasons provided by surgeons for opting to proceed with Mohs surgery, the most common were patient desire for treatment with a high cure rate (712 patients [66.0%]), good or excellent patient functional status for age (614 patients [57.0%]), and high risk associated with the tumor based on histology (433 patients [40.2%]). CONCLUSIONS AND RELEVANCE: This study found that older patients who received Mohs surgery often had high functional status, high-risk tumors, and tumors located on the face. These findings suggest that timely surgical treatment may be appropriate in older patients given that their tumors may be aggressive, painful, disfiguring, and anxiety provoking.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Maisel-Campbell A, Lin KA, Ibrahim SA, et al. Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery: A Prospective, Multicenter Cohort Study. JAMA Dermatol. 2022. PMID: 35612849. doi:10.1001/jamadermatol.2022.1733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。